GRAIL Completes $110 Million Equity Financing With Samsung Entities Accessibility Statement Skip Navigation MENLO PARK, Calif., June 25, 2026 /PRNewswire/ -- GRAIL, Inc. (Nasdaq: GRAL), a healthcare company whose mission is to detect cancer early when it can be cured, today announced the closing of its previously announced equity financing with Samsung affiliates including Samsung C&T Corporation. "GRAIL is at a pivotal moment in its mission to transform early cancer detection. This investment in GRAIL, tog ...